EUROGIN2011 HPV Associated Diseases and Cancer-From Reality now to the Future
May 08, 2011 - May 11, 2011
| Congress Center Lisbon, Portugal
The meeting aimed at developing a full review of current scientific developments in the field of cervical cancer control and beyond, including vulvar, anal and head & neck HPV associated diseases. The event highlight recent advances, and provided a forum for exchanging information on early detection, new diagnostic and therapeutic procedures and prevention strategies including screening and HPV vaccination.
The purpose of the conference was not only to highlight new developments, but also to widen the discussion beyond the purely medical aspects and to address public education issues.
Presentations
Epidemiology of HPV infection Basic research and fundamentals: state of the art
May 08, 2011 09:00 | Length: 36.05 min
Congress: EUROGIN2011
Natural history revisited: age specific relationship and implications for clinical practice Basic research and fundamentals: state of the art
May 08, 2011 09:00
Congress: EUROGIN2011
Vulvar HPV related lesions: current knowledge HPV related neoplasia and cancer in anus, external genitalia and head & neck – facts and figures
May 08, 2011 16:00 | Length: 13.54 min
Congress: EUROGIN2011
Anal neoplasia: epidemiology, diagnostics and prevention HPV related neoplasia and cancer in anus, external genitalia and head & neck – facts and figures
May 08, 2011 16:15
Congress: EUROGIN2011
Penile HPV associated diseases: what the clinician should know HPV related neoplasia and cancer in anus, external genitalia and head & neck – facts and figures
May 08, 2011 16:30
Congress: EUROGIN2011
Head and neck cancer: the significance of HPV infection and treatment issues HPV related neoplasia and cancer in anus, external genitalia and head & neck – facts and figures
May 08, 2011 16:45
Congress: EUROGIN2011
Optimal screening intervals Cervical cancer screening – role of molecular testing
May 09, 2011 08:00
Congress: EUROGIN2011
Current knowledge on screening of women less than 30 Cervical cancer screening – role of molecular testing
May 09, 2011 08:30
Congress: EUROGIN2011
Management of cytonegative / HPV positive women Cervical cancer screening – role of molecular testing
May 09, 2011 08:45
Congress: EUROGIN2011
Exiting women from screening Cervical cancer screening – role of molecular testing
May 09, 2011 09:00
Congress: EUROGIN2011
Cervical cancer screening as a post-vaccination surveillance activity Cervical cancer screening – role of molecular testing
May 09, 2011 09:15
Congress: EUROGIN2011
Vaccine benefits following sexual debut (catch- up/adult) HPV vaccination – current knowledge and the road to the future
May 09, 2011 09:30
Congress: EUROGIN2011
New evidence for vaccination of males HPV vaccination: Current knowledge and the road to the future
May 09, 2011 09:45
Congress: EUROGIN2011
An evaluation of the long-term effectiveness, immunogenicity and safety of the quadrivalent vaccine in previously vaccinated women HPV vaccination: Current knowledge and the road to the future
May 09, 2011 10:00
Congress: EUROGIN2011
The burden of HPV associated penile cancer Penile HPV related diseases revisited
May 09, 2011 14:00
Congress: EUROGIN2011
Male sexual behaviour – a risk factor for cervical cancer? Penile HPV related diseases revisited
May 09, 2011 14:15
Congress: EUROGIN2011
The global spectrum of HPV related diseases in males Penile HPV related diseases revisited
May 09, 2011 14:30
Congress: EUROGIN2011
Management of penile HPV associated lesions Penile HPV related diseases revisited
May 09, 2011 14:45
Congress: EUROGIN2011
HPV vaccination: what have we learned from the clinical trials? Penile HPV related diseases revisited
May 09, 2011 15:00
Congress: EUROGIN2011
Impact of male circumcision on women with HPV genital disease Penile HPV related diseases revisited
May 09, 2011 15:15
Congress: EUROGIN2011
The burden of the diseases and natural history Anal HPV associated diseases and cancer: State of the art
May 09, 2011 15:30
Congress: EUROGIN2011
Factors influencing HPV dysplasia and anal cancer following HPV infection Anal HPV associated diseases and cancer: State of the art
May 09, 2011 15:45
Congress: EUROGIN2011
Diagnostic methods and clinical features Anal HPV associated diseases and cancer: State of the art
May 09, 2011 16:00
Congress: EUROGIN2011
Who should be screened? Is screening an effective tool? Anal HPV associated diseases and cancer: State of the art
May 09, 2011 16:15
Congress: EUROGIN2011
Current management of AIN3 and cancer Anal HPV associated diseases and cancer: State of the art
May 09, 2011 16:30
Congress: EUROGIN2011
Assessing inequalities over the world (access, resources, education) and potential solutions Can we target the adult population at high risk of cervical cancer? Consequences on screening, management and vaccination
May 10, 2011 08:00
Congress: EUROGIN2011
Epidemiologic, genetic, behavioural factors and the male partner influence: are they important? Can we target the adult population at high risk of cervical cancer? Consequences on screening, management and vaccination
May 10, 2011 08:15
Congress: EUROGIN2011
Significance of molecular testing/markers and age of exposure to HPV Can we target the adult population at high risk of cervical cancer? Consequences on screening, management and vaccination
May 10, 2011 08:30
Congress: EUROGIN2011
Integrating and implementing screening and vaccination programs for high risk populations Can we target the adult population at high risk of cervical cancer? Consequences on screening, management and vaccination
May 10, 2011 08:45
Congress: EUROGIN2011
Molecular diagnostic methods and prognostic markers utility Head and neck HPV associated cancer: State of the art
May 10, 2011 10:15
Congress: EUROGIN2011
Tumor HPV status management and survival Head and neck HPV associated cancer: State of the art
May 10, 2011 10:30
Congress: EUROGIN2011
The potential impact of HPV vaccines Head and neck HPV associated cancer: State of the art
May 10, 2011 10:45
Congress: EUROGIN2011
The burden of HPV related head and neck cancer HPV and heterogeneity of head and neck cancers
May 10, 2011 14:15
Congress: EUROGIN2011
Comparison of molecular methods for detection of HPV in oral and oropharyngal squamous carcinoma HPV and heterogeneity of head and neck cancers
May 10, 2011 14:30
Congress: EUROGIN2011
Infos
| Date | May 08, 2011 - May 11, 2011 |
|---|---|
| Program-Link: | http://www.eurogin.com/2011/finalprogram.pdf |
| Website: | http://www.eurogin.com/2011/ |
| Location: | Congress Center Lisbon, Portugal ; |
| Category: | Medicine; |
Latest Presentations
Please activate JavaScript and Flash to see this video.
Videos are not working? If the videos are not working on your computer, make sure you have installed the latest Flash Player and javascript is enabled in your browser.
Latest Congresses
March 15, 2012
November 17, 2011
September 07, 2011
August 31, 2011
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our Terms of use. Warning: Some websites may contain content of an adult nature. These pages are designed for ADULTS only.